Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Edaravone: A new drug approved for ALS
Jeffrey D. Rothstein
Cell (2017) Vol. 171, Iss. 4, pp. 725-725
Open Access | Times Cited: 186

Showing 1-25 of 186 citing articles:

Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1/Nrf2/HO-1/Gpx4 pathway
Ruozhi Dang, Mingyang Wang, Xinhui Li, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 308
A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions
Dean G. Brown, Heike J. Wobst
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 5, pp. 2312-2338
Closed Access | Times Cited: 220
The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Yevgeniya Abramzon, Pietro Fratta, Bryan J. Traynor, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 203
iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders
Hideyuki Okano, Satoru Morimoto
Cell stem cell (2022) Vol. 29, Iss. 2, pp. 189-208
Open Access | Times Cited: 122
Liquid-Liquid Phase Separation of TDP-43 and FUS in Physiology and Pathology of Neurodegenerative Diseases
Jenny L. Carey, Lin Guo
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 102
Molecular mechanisms of ischemia and glutamate excitotoxicity
Diogo Neves, Ivan L. Salazar, Ramiro D. Almeida, et al.
Life Sciences (2023) Vol. 328, pp. 121814-121814
Open Access | Times Cited: 87
ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries
Bowen Jia, Jing Li, Yiting Song, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10021-10021
Open Access | Times Cited: 48
Ferroptosis inhibitors: past, present and future
Lei Zhang, Yi Luo, Yang Xiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 20
Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities
Juan I. Sbodio, Solomon H. Snyder, Bindu D. Paul
Antioxidants and Redox Signaling (2018) Vol. 30, Iss. 11, pp. 1450-1499
Open Access | Times Cited: 114
Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis
Leeanne McGurk, Jelena Mojsilovic‐Petrovic, Vivianna M. Van Deerlin, et al.
Acta Neuropathologica Communications (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 99
The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients
Qianqian Zeng, Jie Shen, Kangzhi Chen, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 96
Ropinirole, a New ALS Drug Candidate Developed Using iPSCs
Hideyuki Okano, Daisuke Yasuda, Koki Fujimori, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 2, pp. 99-109
Open Access | Times Cited: 81
Increased Interleukin-6 Levels in the Astrocyte-Derived Exosomes of Sporadic Amyotrophic Lateral Sclerosis Patients
Yong Chen, Kailin Xia, Lu Chen, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 80
The cannabinoid system and microglia in health and disease
Samuel S. Duffy, Jessica P. Hayes, Nathan T. Fiore, et al.
Neuropharmacology (2021) Vol. 190, pp. 108555-108555
Closed Access | Times Cited: 71
1-phenyl-3-methyl-5-pyrazolone activates the AMPK pathway to alleviate western-diet induced metabolic dysfunction-associated steatohepatitis in mice
Xiaoning Chen, Jiaofeng Huang, Yue You, et al.
Clinical Nutrition (2025) Vol. 45, pp. 136-147
Closed Access | Times Cited: 1
Nicotinamide Riboside Enhances Mitochondrial Proteostasis and Adult Neurogenesis through Activation of Mitochondrial Unfolded Protein Response Signaling in the Brain of ALS SOD1G93A Mice
Qi Zhou, Lei Zhu, Weiwen Qiu, et al.
International Journal of Biological Sciences (2019) Vol. 16, Iss. 2, pp. 284-297
Open Access | Times Cited: 66
Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review
Sandra Carrera‐Juliá, Mari Luz Moreno, Carlos Barrios, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 66
Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics
Ranjeet Prasad Dash, R. Jayachandra Babu, Nuggehally R. Srinivas
Clinical Pharmacokinetics (2018) Vol. 57, Iss. 11, pp. 1385-1398
Closed Access | Times Cited: 64
Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis
Guoying Wang, Stephanie L. Rayner, Roger S. Chung, et al.
Materials Today Bio (2020) Vol. 6, pp. 100055-100055
Open Access | Times Cited: 63
Structural Variants May Be a Source of Missing Heritability in sALS
Frances Theunissen, Loren L. Flynn, Ryan S. Anderton, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 52
A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed?
Xiaojiao Xu, Dingding Shen, Yining Gao, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 49
Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases
Sajad Fakhri, Sadaf Abdian, Seyede Nazanin Zarneshan, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 299-331
Open Access | Times Cited: 34
Edaravone Modulates Neuronal GPX4/ACSL4/5-LOX to Promote Recovery After Spinal Cord Injury
Yilin Pang, Xinjie Liu, Xu Wang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 32
Drug discovery and amyotrophic lateral sclerosis: Emerging challenges and therapeutic opportunities
Pedro Soares, Catia Silva, Daniel Chavarria, et al.
Ageing Research Reviews (2022) Vol. 83, pp. 101790-101790
Open Access | Times Cited: 31
Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis
Emmanuelle C. Genin, Mélanie Abou-Ali, Véronique Paquis‐Flucklinger
Genes (2023) Vol. 14, Iss. 11, pp. 1981-1981
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top